Shah Mihir's Form 4 filing
Starling Oncology, Inc. (DFPH) · filed Dec 18, 2023
- Accession no.
- 0001628280-23-041777
- Filed
- Dec 18, 2023
- Trade date
- Dec 14, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $127.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shah MihirCIK 0001676960 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Common stock | PPurchaseAcquired | +99,435 | $1.27 | +$126,282.45 | 327,557 | Direct | |
| Dec 14, 2023 | Common stock | PPurchaseAcquired | +565 | $1.25 | +$706.25 | 328,122 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.